X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (7) 7
humans (7) 7
index medicus (7) 7
child (6) 6
female (6) 6
bone-marrow-transplantation (5) 5
child, preschool (5) 5
hematology, oncology and palliative medicine (5) 5
male (5) 5
transplantation, homologous (5) 5
adolescent (4) 4
infant (4) 4
oncology (4) 4
radiation (4) 4
retrospective studies (4) 4
stem cell transplantation (4) 4
care and treatment (3) 3
engraftment (3) 3
fanconi anemia (3) 3
fanconi anemia - therapy (3) 3
fanconi's anemia (3) 3
graft vs host disease - etiology (3) 3
hematopoietic stem cell transplantation (3) 3
immunology (3) 3
low-dose cyclophosphamide (3) 3
pediatrics (3) 3
transplantation (3) 3
treatment outcome (3) 3
antilymphocyte serum - therapeutic use (2) 2
antithymocyte globulin (2) 2
children (2) 2
cord blood stem cell transplantation (2) 2
cyclophosphamide (2) 2
cyclophosphamide - administration & dosage (2) 2
cyclophosphamide - therapeutic use (2) 2
cystitis - immunology (2) 2
disease-free survival (2) 2
fanconi anemia - immunology (2) 2
fanconi anemia - mortality (2) 2
graft failure (2) 2
histocompatibility testing (2) 2
immunosuppressive agents - therapeutic use (2) 2
patient outcomes (2) 2
rejection (2) 2
stem cells (2) 2
transplantation conditioning (2) 2
transplantation conditioning - methods (2) 2
treatment failure (2) 2
unrelated donors (2) 2
vidarabine - analogs & derivatives (2) 2
1st complete remission (1) 1
acquired aplastic-anemia (1) 1
acute myeloblastic-leukemia (1) 1
acute myelogenous leukemia (1) 1
acute myeloid leukemia (1) 1
age (1) 1
age factors (1) 1
analysis (1) 1
anemia (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antibodies, viral - blood (1) 1
antilymphocyte serum - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antithymocyte globulins (1) 1
aplastic-anemia (1) 1
blood (1) 1
busulfan - administration & dosage (1) 1
cancer (1) 1
cancer group (1) 1
carcinoma, squamous cell - chemically induced (1) 1
carcinoma, squamous cell - immunology (1) 1
carcinoma, squamous cell - mortality (1) 1
carcinoma, squamous cell - pathology (1) 1
case-control studies (1) 1
chronic myeloid-leukemia (1) 1
conditioning regimens (1) 1
cord blood (1) 1
cyclophosphamide - adverse effects (1) 1
cyclosporine - adverse effects (1) 1
cyclosporine - therapeutic use (1) 1
cystitis - chemically induced (1) 1
cystitis - mortality (1) 1
cystitis - pathology (1) 1
cystitis - prevention & control (1) 1
cytomegalovirus - immunology (1) 1
cytomegalovirus infections - epidemiology (1) 1
cytomegalovirus infections - etiology (1) 1
cytomegalovirus infections - virology (1) 1
data processing (1) 1
donor (1) 1
drug therapy, combination (1) 1
etoposide (1) 1
etoposide - administration & dosage (1) 1
european group (1) 1
failure syndromes (1) 1
fanconi anemia - pathology (1) 1
fanconi anemia - radiotherapy (1) 1
fanconi-anemia (1) 1
follow-up studies (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2012, Volume 18, Issue 4, pp. 627 - 632
Low-dose cyclophosphamide (CY) is now considered the backbone of many of the conditioning regimens used in patients with Fanconi anemia undergoing allogeneic... 
Hematology, Oncology and Palliative Medicine | Graft-versus-host disease | Cyclophosphamide | Antithymocyte globulin | Radiation | DONOR | BONE-MARROW-TRANSPLANTATION | LOW-DOSE CYCLOPHOSPHAMIDE | IMMUNOLOGY | CHILDREN | TRANSPLANTATION | ENGRAFTMENT | UPDATE | HEMATOLOGY | APLASTIC-ANEMIA | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Cystitis - immunology | Infant | Male | Antilymphocyte Serum - administration & dosage | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Fanconi Anemia - mortality | Transplantation, Homologous | Saudi Arabia | Cystitis - prevention & control | Antilymphocyte Serum - therapeutic use | Female | Unrelated Donors | Child | Immunosuppressive Agents - administration & dosage | Histocompatibility Testing | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Cord Blood Stem Cell Transplantation | Disease-Free Survival | Adolescent | Graft vs Host Disease - prevention & control | Fanconi Anemia - immunology | Fanconi Anemia - therapy | Vidarabine - administration & dosage | Transplantation Conditioning | Stem cell research | Care and treatment | Anemia | Nuclear radiation | Patient outcomes | Influenza | Stem cells | Transplantation | Children | Health aspects | Fanconi's anemia | Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 10, pp. 1599 - 1603
Abstract Hematopoietic cell transplantation (HCT) can cure bone marrow failure in patients with Fanconi Anemia (FA), and it is generally accepted that these... 
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | Cyclophosphamide | Fanconi anemia | Radiation | BONE-MARROW-TRANSPLANTATION | LOW-DOSE CYCLOPHOSPHAMIDE | ANTITHYMOCYTE GLOBULIN | EUROPEAN GROUP | CONDITIONING REGIMENS | IMMUNOLOGY | VERSUS-HOST-DISEASE | MYELODYSPLASTIC SYNDROME | ACQUIRED APLASTIC-ANEMIA | TRANSPLANTATION | MATCHED UNRELATED DONORS | FAILURE SYNDROMES | HEMATOLOGY | Oropharyngeal Neoplasms - immunology | Gamma Rays - adverse effects | Myeloablative Agonists - adverse effects | Carcinoma, Squamous Cell - pathology | Humans | Carcinoma, Squamous Cell - chemically induced | Oropharyngeal Neoplasms - mortality | Child, Preschool | Hemorrhage - mortality | Cystitis - immunology | Infant | Male | Oropharyngeal Neoplasms - pathology | Cyclophosphamide - adverse effects | Fanconi Anemia - mortality | Transplantation, Homologous | Carcinoma, Squamous Cell - mortality | Fanconi Anemia - pathology | Female | Unrelated Donors | Retrospective Studies | Transplantation Conditioning - methods | Child | Siblings | Histocompatibility Testing | Hemorrhage - immunology | Vidarabine - adverse effects | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Carcinoma, Squamous Cell - immunology | Cystitis - mortality | Cystitis - pathology | Oropharyngeal Neoplasms - chemically induced | Adolescent | Survival Analysis | Fanconi Anemia - immunology | Fanconi Anemia - therapy | Hemorrhage - chemically induced | Cystitis - chemically induced | Hemorrhage - pathology | Care and treatment | Squamous cell carcinoma | Patient outcomes | Analysis | Transplantation | Hematopoietic stem cells | Fanconi's anemia | Index Medicus
Journal Article
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 07/2019
Allogeneic Hematopoietic Cell Transplantation (HCT) has been shown to restore normal hematopoiesis in Fanconi anemia (FA) patients with excellent results in... 
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 04/2012, Volume 18, Issue 4, pp. A5,A8 - A6,A8
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2008, Volume 14, Issue 4, pp. A11 - A12
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2008, Volume 14, Issue 4, pp. A11 - A12
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.